News – Page 1097 – Endpoints News

Amplyx grabs $67M to fund a pivotal drive to the FDA with an anti-fungal aimed at a lethal threat

8 years ago

Updated: Celgene, Agios win a landmark FDA OK for new AML drug Idhifa

8 years ago

Despite blockbuster boasts for R&D work, pressure increases on Pfizer to do a megadeal

8 years ago

Lexicon grabs co-promo option on diabetes drug; Shkreli jury enters second day of deliberations

8 years ago

Indivior gets a speedy review for opioid addiction drug as FDA vows to fight a crisis

8 years ago

Looking for an oncology reboot, Sanofi, Regeneron shoot for a fast and flashy FDA OK of a promising new PD-1

8 years ago

After taking a PhIII thrashing, AstraZeneca comes out swinging with breakthrough titles, new cancer hires

8 years ago

Milestone Pharma preps a leap into PhIII cardio study with $55M round backed by Novo

8 years ago

A fast-moving entry in the gene editing race is speeding to the clinic, fueled by an $83.5M round

8 years ago

FDA slams J&J’s blockbuster contender sirukumab on ‘important safety risks’

8 years ago

AstraZeneca bags a ‘breakthrough’ for bruised checkpoint drug Imfinzi; Inotek CSO takes the helm at Flex

8 years ago

InVivo Therapeutics shares tank after a third patient death in lead study

8 years ago

Kite shoots for first CAR-T OK in Europe, staying one step behind Novartis in US race

8 years ago

Bristol-Myers, Clovis leap into PhIII combo studies in a PD-1/PARP play as rivals circle

8 years ago

Loxo beefs up its genetics-based cancer drug pipeline with an unusual $40M deal

8 years ago

LabCorp nabs Chiltern, boosting its big Covance CRO group to 20K-plus staffers in $1.2B deal

8 years ago

Dynavax takes a big step toward an OK for hep B vaccine, but nagging safety issues remain

8 years ago

Evotec expands global discovery, development ops with $300M Aptuit buyout

8 years ago

Merck admits cyberattack is having an impact on research, manufacturing — we're just not sure how big

8 years ago

Idorsia touts new sleep drug data ahead of PhIII; Tetraphase out to raise $65M

8 years ago

Biotech billionaire Soon-Shiong picks up rights to CytRx’s troubled cancer drug

8 years ago

The global rivalry for top scientific talent in biopharma R&D is about to get a lot hotter

8 years ago

CheckMate-227: Bristol-Myers Squibb has a MYSTIC-sized problem on its hands

8 years ago

GSK's Moncef Slaoui joins the board at Moderna; Aduro promotes van Elsas to CSO

8 years ago

First page Previous page 1094 1095 109610971098 1099 1100 Next page Last page